World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 30 May 2016
Main ID:  NCT00189124
Date of registration: 13/09/2005
Prospective Registration: No
Primary sponsor: University of Michigan
Public title: Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention
Scientific title: Does DHEA Improve Endothelial Dysfunction and Other Cardiovascular Risk Factors in Premenopausal Women With Systemic Lupus?
Date of first enrolment: September 2003
Target sample size: 13
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT00189124
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment  
Phase:  Phase 2/Phase 3
Countries of recruitment
United States
Contacts
Name:     Wendy Marder, MD
Address: 
Telephone:
Email:
Affiliation:  University of Michigan
Key inclusion & exclusion criteria

Inclusion Criteria:

- Female

- Member of the Michigan Lupus Cohort

- Meet the American College of Rheumatology (ACR) criteria for SLE

- Premenopausal

Exclusion Criteria:

- Smoker

- Diabetic

- Prednisone dose > 10 mg



Age minimum: 18 Years
Age maximum: N/A
Gender: Female
Health Condition(s) or Problem(s) studied
Systemic Lupus Erythematosus
Intervention(s)
Drug: Dehydroepiandrosterone (DHEA)
Primary Outcome(s)
Brachial artery reactivity, by flow mediated dilatation
Secondary Outcome(s)
Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) score
Changes in biomarkers of SLE
Secondary ID(s)
2001-0822
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Arthritis Foundation
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history